BUY ANY 2+ LONZA PRODUCTS AND SAVE 10% ON EACH - INCLUDING LONZA BULLETKITS™
Tweet, Share, View all associated products with this promotion!
View a complete listing of all associated products with this promotion. Still need more help? Please contact customer service to relieve any additional questions you may have.
Mix and Match Savings on all Lonza Products!
Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing.
Lonza is dedicated to focusing on the customers’ research and development and manufacturing needs in clearly defined life science markets. Lonza also makes optimal use of and further develops high-tech biology and chemical technology platforms in accordance with best serving the scientific research community. Lonza is committed to harnessing science and technology to create products that make people's and animals' lives healthier and that enhance the overall quality of life and well-being. Its products and services range from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens, from the manufacture of vitamin B compounds and organic personal care ingredients to agricultural services and products.
Primary Product Categories
- Stem Cells
- Primary Cells and Media
- Cell Culture Products
- CytoSMART™ System
- Assay Solutions
- Drug Discovery
- Endotoxin Detection
Click here to view a complete listing of applicable products.
Featured Product: BulletKits™
Clonetics™ is the pioneer of human primary cells. In 1984, the company was the first to develop a novel technology which allowed culturing of human primary cells outside of their tissue origin. This was a crucial step forward in the research community as scientists now had the capacity to study tissue specific characteristics on a cellular level in vitro and develop more biologically relevant models.
Clonetics™ first led its primary cell business with select cell types. Overtime, the portfolio has grown to more than 100+ cell types spanning numerous research areas. The portfolio quality has also expanded to include normal as well as diseased cells from asthma, COPD, diabetes and cystic fibrosis tissue. For each cell type, careful consideration is given to maintain broad donor variety, highest quality control, batch-to-batch consistency, and large-scale production capacity. Lonza’s Clonetics™, by far, is the largest primary cells portfolio being offered commercially.
Clonetics™ Media Kits have been specially designed to support the growth of Clonetics™ cells. Each media BulletKit™ is comprised of basal media and a SingleQuot™ Kit of growth factors and supplements.
Have questions? Need more information? Contact us at email@example.com to have all your questions answered in a timely and professional manner.
Note: This offer is not valid in conjunction with contract discounts or any other special pricing. Void where prohibited. Discount does not apply to ALL Lonza products; some restrictions apply. Contact your Cedarlane Sales or Customer Service Representative for further details.